XML 66 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill - Rollforward (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2022
Goodwill [Roll Forward]                      
Beginning balance     $ 3,006.0       $ 3,006.0   $ 3,006.0    
Goodwill, Acquired During Period                 216.0    
Goodwill, Transfers                 0.0    
Foreign currency translation adjustments                 11.0    
Ending balance $ 3,023.0               $ 3,023.0   $ 3,006.0
Goodwill Input, Discount Rate Minimum, Percentage 10.50%               10.50%    
Net revenue $ 1,037.0   1,015.0 $ 1,273.0         $ 3,208.0 $ 3,515.0 4,802.0
Inter-segment revenue elimination $ (1.0) $ (1.0) 0.0 (1.0) $ (1.0) $ (1.0) (1.0) $ (2.0) $ (2.0) (3.0)  
Goodwill Inputs Long Term Revenue Growth Rate, Percentage 3.00%               3.00%    
Goodwill Input, Discount Rate Minimum, Percentage 10.50%               10.50%    
Goodwill Input Discount Rate Minimum, Percentage 9.00%               9.00%    
Goodwill, Impairment Loss $ (210.0)     0.0         $ (210.0) 0.0  
Biologics                      
Goodwill [Roll Forward]                      
Beginning balance     1,535.0       1,535.0   1,535.0    
Goodwill, Acquired During Period                 0.0    
Goodwill, Transfers                 16.0    
Foreign currency translation adjustments                 7.0    
Ending balance 1,558.0               1,558.0   1,535.0
Net revenue 475.0     700.0         1,578.0 1,889.0  
Biologics | Manufacturing & Commercial Product Supply                      
Goodwill [Roll Forward]                      
Net revenue 133.0     200.0         303.0 503.0  
Biologics | Development Services                      
Goodwill [Roll Forward]                      
Net revenue 342.0     500.0         1,275.0 1,386.0  
PharmaConsumerHealth                      
Goodwill [Roll Forward]                      
Beginning balance     $ 1,471.0       $ 1,471.0   1,471.0    
Goodwill, Acquired During Period                 216.0    
Goodwill, Transfers                 (16.0)    
Foreign currency translation adjustments                 4.0    
Ending balance 1,465.0               1,465.0   $ 1,471.0
Net revenue 563.0     574.0         1,632.0 1,629.0  
Goodwill, Impairment Loss (210.0)     0.0         (210.0) 0.0  
PharmaConsumerHealth | Manufacturing & Commercial Product Supply                      
Goodwill [Roll Forward]                      
Net revenue 349.0     368.0         1,027.0 1,042.0  
PharmaConsumerHealth | Development Services                      
Goodwill [Roll Forward]                      
Net revenue 214.0     206.0         605.0 587.0  
Total Catalent before inter-segment revenue elimination                      
Goodwill [Roll Forward]                      
Net revenue 1,038.0     1,274.0         3,210.0 3,518.0  
Total Catalent before inter-segment revenue elimination | Manufacturing & Commercial Product Supply                      
Goodwill [Roll Forward]                      
Net revenue 482.0     568.0         1,330.0 1,545.0  
Total Catalent before inter-segment revenue elimination | Development Services                      
Goodwill [Roll Forward]                      
Net revenue $ 556.0     $ 706.0         $ 1,880.0 $ 1,973.0